NCT04360044 - Efficacy of Inhaled Cannabis for Acute Migraine Treatment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 23, 2023

Study Completion Date

February 23, 2023

Conditions

MigraineCannabisTHCCBD

Interventions

DRUG

THC ~5%

4 puffs of vaporized flower containing THC \~5%

DRUG

CBD ~12%

4 puffs of vaporized flower containing CBD \~12%

DRUG

THC ~5% and CBD ~12%

4 puffs of vaporized flower containing THC \~5% and CBD \~12%

DRUG

Sham Cannabis

4 puffs of vaporized flower from which the THC and CBD have been extracted

Trial Locations (1)

Center for Pain Medicine, UC San Diego, La Jolla